GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiang Xi Sanxin Medtec Co Ltd (SZSE:300453) » Definitions » 3-Year ROIIC %

Jiang Xinxin Medtec Co (SZSE:300453) 3-Year ROIIC % : 15.10% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Jiang Xinxin Medtec Co 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Jiang Xinxin Medtec Co's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 15.10%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Jiang Xinxin Medtec Co's 3-Year ROIIC % or its related term are showing as below:

SZSE:300453's 3-Year ROIIC % is ranked better than
68.8% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: -1.545 vs SZSE:300453: 15.10

Jiang Xinxin Medtec Co 3-Year ROIIC % Historical Data

The historical data trend for Jiang Xinxin Medtec Co's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiang Xinxin Medtec Co 3-Year ROIIC % Chart

Jiang Xinxin Medtec Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.88 21.27 44.50 34.24 15.10

Jiang Xinxin Medtec Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 15.10 -

Competitive Comparison of Jiang Xinxin Medtec Co's 3-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Jiang Xinxin Medtec Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiang Xinxin Medtec Co's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jiang Xinxin Medtec Co's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Jiang Xinxin Medtec Co's 3-Year ROIIC % falls into.



Jiang Xinxin Medtec Co 3-Year ROIIC % Calculation

Jiang Xinxin Medtec Co's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 217.88544 (Dec. 2023) - 128.6877945 (Dec. 2020) )/( 1518.24 (Dec. 2023) - 927.341 (Dec. 2020) )
=89.1976455/590.899
=15.10%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Jiang Xinxin Medtec Co  (SZSE:300453) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Jiang Xinxin Medtec Co 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Jiang Xinxin Medtec Co's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiang Xinxin Medtec Co (SZSE:300453) Business Description

Traded in Other Exchanges
N/A
Address
No. 999 Fushan Road, Xiaolan Economic and Technological Development Zone, Jiangxi, Nanchang, CHN, 330200
Jiang Xi Sanxin Medtec Co Ltd is engaged in researching and developing, manufacturing and marketing of medical devices. Its products include four series: blood purification, indwelling catheters, injections, infusion and blood transfusion. Blood purification products are used in clinical dialysis treatment for uremic patients. Indwelling catheter products represented by venous indwelling needles, positive pressure indwelling needles, central venous catheters. Injectable products mainly include self-destructing syringes, retracting self-destructing syringes, conjoined syringes.

Jiang Xinxin Medtec Co (SZSE:300453) Headlines

No Headlines